Emerging evidence reveals that enhanced activity of Bruton’s tyrosine kinase (Btk) in peripheral blood B cells promotes IL-21-mediated signaling pathway by inducing nuclear phosphorylated STAT1 levels in patients with autoimmune disease (29, 30). The gene discussed is BTK; the disease is autoimmune disease.